We operate a diversified business model across three core businesses:
The first and largest is our Branded business, which focuses on
the MENA region. In this business we manufacture and sell Branded
generic pharmaceuticals – for example, we sell a generic version of
GSK’s Augmentin under our own Hikma brand name – AMOCLAN. We also
have 20 Branded products, many of which are still under patent,
that we sell under-license from the originator.
» Find out more about our Branded
business
Our second largest business is the Generic business. Here we
sell un-branded generic pharmaceuticals into the US market. As this
market is extremely competitive, we operate as a niche player,
selling a broad mix of both high and low volume products.
» Find out more about our Generic
business
Our newest business is the Injectable business. Here we
manufacture and sell generic injectable pharmaceuticals as well as
some branded injectable products under-licence. This business is
geographically diverse with sales into US, MENA and Europe.
» Find out more about our Injectable
business